✦ LIBER ✦

An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization

✍ Scribed by Franck Lemiale; Benyam Asefa; Delia Ye; Christopher Chen; Nikolay Korokhov; Laurent Humeau

Book ID: 116962180
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 999 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.10.089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of a multi-lipopeptides

Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate

✍ Christine Klinguer; Dominique David; Mostafa Kouach; Jean-Michel Wieruszeski; An 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Design and immunogenicity assessment of

Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine

✍ XiZhen Zhang; XiaoDan Wang; DongHai Zhao; XiangYu Meng; XingHong Zhao; XiangHui 📂 Article 📅 2011 🏛 Science in China Press (SCP) 🌐 English ⚖ 695 KB

Recombinant vesicular stomatitis virus a

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

✍ Clarke, David K. ;Cooper, David ;Egan, Michael A. ;Hendry, R. Michael ;Parks, Ch 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 617 KB

Ovine atadenovirus, a novel and highly i

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine

✍ Anne Bridgeman; Yaowaluck Roshorm; Linda J. Lockett; Zheng-Zhou Xu; Richard Hopk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 915 KB

Construction of an Artificial Immunogen,

Construction of an Artificial Immunogen, a Candidate DNA Vaccine Encoding Multiple CTL Epitopes of HIV-1

✍ S. I. Bazhan; P. A. Belavin; S. V. Seregin; N. K. Danilyuk; I. N. Babkina; L. I. 📂 Article 📅 2004 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 56 KB

From pathogen to medicine: HIV-1-derived

From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy

✍ Melissa Dullaers; Kris Thielemans 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Over the years, the unique capacity of dendritic cells (DC) for efficient activation of naive T cells has led to their extensive use in cancer immunotherapy protocols. In order to be able to fulfil their role as antigen-presenting cells, the antigen of interest needs to be efficiently introduced and